NAD supplementation dosage in clinical studies
Pro Research Analysisby 
Searched over 200M research papers
NMN and NAD Supplementation Dosage in Clinical Studies
Dosage Ranges and Study Designs for NMN Supplementation
Clinical studies on nicotinamide mononucleotide (NMN), a precursor to NAD, have tested a range of daily oral dosages from 150 mg up to 1200 mg in healthy adults. Most commonly, studies use 250–900 mg/day for durations between 4 and 12 weeks, with some trials extending up to 60 days or more 1347. These studies are typically randomized, double-blind, and placebo-controlled, ensuring reliable results.
Effects of Different NMN Dosages on NAD Levels
Across multiple studies, NMN supplementation at 300 mg, 600 mg, and 900 mg daily significantly increased blood NAD concentrations compared to placebo. The increase was dose-dependent, with the highest NAD levels observed in the 600 mg and 900 mg groups 124. A systematic review of randomized controlled trials confirmed that NMN dosages between 250–900 mg/day consistently improved blood NAD levels with only mild adverse effects reported .
Physical Performance and Health Outcomes
Improvements in physical performance, such as increased walking distance in the six-minute walk test, were observed at all tested NMN dosages (300 mg, 600 mg, and 900 mg), with the most pronounced effects at 600 mg and 900 mg daily 13. Systematic reviews also noted non-significant but positive trends in grip strength and skeletal muscle index with NMN supplementation, and no serious adverse effects were reported .
Safety and Tolerability of NMN Supplementation
NMN supplementation up to 900 mg daily was well tolerated, with no significant safety concerns or serious adverse events reported in any of the clinical trials 147. Mild side effects, when present, were not directly linked to NMN use.
Interindividual Variability and Personalized Dosing
There is considerable variability in how individuals respond to NMN supplementation, with changes in NAD levels ranging widely within dosage groups. This suggests that monitoring NAD concentrations could help tailor personalized NMN dosing regimens for optimal benefit .
Other NAD Precursors: Nicotinamide Riboside and Nicotinamide
Studies on other NAD precursors, such as nicotinamide riboside (NR) and nicotinamide, have also shown dose-dependent increases in NAD+ levels. For example, oral NR at 500 mg and 1000 mg daily, as well as intravenous NR at 500 mg, significantly increased NAD+ concentrations in healthy adults and specific patient populations, with good safety profiles 6810. Nicotinamide supplementation at 200 mg (single dose) also increased NAD+ levels, though effects were transient and varied by individual .
Combination Supplements
A combination of nicotinamide and D-ribose (RiaGev) at 1520 mg twice daily for 7 days was found to safely increase the NAD+ metabolome and improve related metabolic markers in healthy middle-aged adults .
Conclusion
Clinical studies consistently show that NMN supplementation in the range of 250–1200 mg/day, most commonly 300–900 mg/day, is effective at increasing blood NAD levels and is well tolerated in healthy adults. The optimal dose for maximal NAD increase and physical performance benefits appears to be around 600 mg daily, though individual responses vary. Other NAD precursors, such as NR and nicotinamide, also demonstrate dose-dependent NAD+ increases with good safety profiles. Monitoring NAD levels may help personalize dosing for best results.
Sources and full results
Most relevant research papers on this topic